Cargando…

The State of Cancer Care in the United Arab Emirates in 2022

Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in t...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Shamsi, Humaid O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777273/
https://www.ncbi.nlm.nih.gov/pubmed/36547109
http://dx.doi.org/10.3390/clinpract12060101
_version_ 1784856062851022848
author Al-Shamsi, Humaid O.
author_facet Al-Shamsi, Humaid O.
author_sort Al-Shamsi, Humaid O.
collection PubMed
description Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in the UAE nowadays. Despite the significant progress in medical care, cancer quality control across the UAE is still lacking, with significant variations in cancer care across the cancer centers. Access to clinical trials is still hampered by a lack of expertise and research infrastructure and a small population, which renders patient accrual for trials a major challenge. Education and training are other areas for improvement that require immediate attention, and, in this review, we try to address these critical aspects for stakeholders to consider better cancer care in the UAE. Early cancer detection and screening are still evolving in the UAE, and a national screening program is lacking. There is also a need to address barriers to screening and to consider less invasive screening methods such as approved blood-based screening, which is likely to be more acceptable to the UAE population. In this review, we also address new topics that have not been addressed previously, including oncology medical tourism, psycho-oncology, onco-fertility, precision oncology, survivorship, oncology nursing, cancer support programs, and the oncology sector’s response to the COVID-19 pandemic, all in the context of the UAE cancer landscape. Finally, we provide recommendations for policymakers, regulators, payers, patient advocacy groups, and the UAE oncology community regarding the delivery and future planning of high-quality cancer care. These recommendations are aligned with the UAE government’s vision to reduce cancer mortality and provide high-quality healthcare for its citizens and residents.
format Online
Article
Text
id pubmed-9777273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97772732022-12-23 The State of Cancer Care in the United Arab Emirates in 2022 Al-Shamsi, Humaid O. Clin Pract Review Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in the UAE nowadays. Despite the significant progress in medical care, cancer quality control across the UAE is still lacking, with significant variations in cancer care across the cancer centers. Access to clinical trials is still hampered by a lack of expertise and research infrastructure and a small population, which renders patient accrual for trials a major challenge. Education and training are other areas for improvement that require immediate attention, and, in this review, we try to address these critical aspects for stakeholders to consider better cancer care in the UAE. Early cancer detection and screening are still evolving in the UAE, and a national screening program is lacking. There is also a need to address barriers to screening and to consider less invasive screening methods such as approved blood-based screening, which is likely to be more acceptable to the UAE population. In this review, we also address new topics that have not been addressed previously, including oncology medical tourism, psycho-oncology, onco-fertility, precision oncology, survivorship, oncology nursing, cancer support programs, and the oncology sector’s response to the COVID-19 pandemic, all in the context of the UAE cancer landscape. Finally, we provide recommendations for policymakers, regulators, payers, patient advocacy groups, and the UAE oncology community regarding the delivery and future planning of high-quality cancer care. These recommendations are aligned with the UAE government’s vision to reduce cancer mortality and provide high-quality healthcare for its citizens and residents. MDPI 2022-11-23 /pmc/articles/PMC9777273/ /pubmed/36547109 http://dx.doi.org/10.3390/clinpract12060101 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Al-Shamsi, Humaid O.
The State of Cancer Care in the United Arab Emirates in 2022
title The State of Cancer Care in the United Arab Emirates in 2022
title_full The State of Cancer Care in the United Arab Emirates in 2022
title_fullStr The State of Cancer Care in the United Arab Emirates in 2022
title_full_unstemmed The State of Cancer Care in the United Arab Emirates in 2022
title_short The State of Cancer Care in the United Arab Emirates in 2022
title_sort state of cancer care in the united arab emirates in 2022
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777273/
https://www.ncbi.nlm.nih.gov/pubmed/36547109
http://dx.doi.org/10.3390/clinpract12060101
work_keys_str_mv AT alshamsihumaido thestateofcancercareintheunitedarabemiratesin2022
AT alshamsihumaido stateofcancercareintheunitedarabemiratesin2022